Memory Disorders Center Launch Offers Hope for Patients, Families
CINCINNATIPatients and families dealing with memory loss issues will gain an important resource with the official opening of the Memory Disorders Center at the UC Neuroscience Institute on Thursday, May 12, at the UC Health Physicians Office in West Chester.
"Were committed to addressing memory disorders and Alzheimers disease with compassionate care that serves the needs of patients and their families in the Greater Cincinnati area, says Brendan Kelley, MD, the centers director and an associate professor in the University of Cincinnati (UC) Department of Neurology.
Kelleys work is supported by an Endowed Chair in Alzheimers Disease Research and Education, which was established in 2008 with a $1.5 million gift from anonymous donors. That endowment has since grown to over $2 million.
According to the U.S. Centers for Disease Control and Prevention, it is estimated that over 5 million Americans have Alzheimers disease, the most common form of dementia among older adults. In addition, Kelley points out, there are more than 100 conditions associated with cognitive declineincluding trauma, substance abuse, heredity, cardiovascular disease, diabetes, brain tumors and vitamin deficiencies. Many of these conditions are treatable, offering the possibility of substantial improvement in cognitive and behavioral symptoms.
"Through a comprehensive evaluation, the center can differentiate between benign forgetfulness associated with normal aging, mild cognitive impairment and more significant cognitive disturbances such as dementia due to Alzheimers disease, says Kelley.
Kelley, a native of Ohio who trained at Ohio State University, the Cleveland Clinic and the Mayo Clinic, is joined by a second behavioral neurologist, Jennifer Rose Molano, MD. Michael Keys, MD, director of senior adult psychiatry at the Lindner Center of HOPE, is another key team member of the Memory Disorders Center.
Patients will be seen at the UC Health physicians offices in West Chester and Clifton. The centers physicians also have expertise in diagnosing and treating rare cognitive diseases, such as primary progressive aphasia, frontotemporal dementia and autoimmune encephalopathy.
"We take a patient-centered approach that emphasizes the importance of lifestyle modifications and community support in addition to medication management, says Kelley, who adds that the Memory Disorders Center will partner closely with regional organizations such as the Alzheimers Association, the Council on Aging of Southwestern Ohio and the Ohio Geriatrics Society.
The launch, for invited guests, begins with a reception at 6 p.m., followed by a ribbon-cutting ceremony and an optional tour.
The Memory Disorders Center is one of eight specialty centers within the UC Neuroscience Institute (UCNI), a leading treatment, research and teaching center for complex neurological conditions. UCNIs team includes more than 100 faculty members from 14 clinical specialties, with additional centers specializing in brain tumors, cerebrovascular disease and stroke, epilepsy, neurosensory disorders, neurotrauma, Parkinsons disease and movement disorders and multiple sclerosis.
Tags
Related Stories
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.